Seeing Is Believing
Healthcare - Sector
with an average price target of $-3.4. This is a potential upside of $-7.74 (-178.34%) from yesterday's end of day stock price of $4.34.
Lumos Pharma's activity chart (see below) currently has 42 price targets and 45 ratings on display.
Analysts average stock forecasts to be materialized ratio is 68.33% with an average time for these price targets to be met of 322.91 days.
Most recent stock forecast was given by EDWARD WHITE from HCWAINWRIGHT on 08-Nov-2024. First documented stock forecast 10-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Oct-2024
$4.25
$-0.09 (-2.07%)
$4.25
1 years 3 months 15 days ago
(08-Nov-2024)
1/5 (20%)
$-0.11 (-2.52%)
148
Buy Since 20-Jul-2022
1 years 6 months 21 days ago
(02-Aug-2024)
0/1 (0%)
$12.65 (172.11%)
Buy Since 02-Dec-2020
$10
$5.66 (130.41%)
$10
2 years 6 months 1 days ago
(22-Aug-2023)
1/4 (25%)
$7.03 (236.70%)
28
Hold Since 14-Nov-2022
$7
$2.66 (61.29%)
3 years 2 months 15 days ago
(08-Dec-2022)
2/3 (66.67%)
$2.8 (66.67%)
79
Buy Since 01-May-2020
$26
3 years 3 months 9 days ago
(14-Nov-2022)
2/5 (40%)
$17.95 (222.98%)
182
What is LUMO (Lumos Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?
Which analyst has the most public recommendations on LUMO (Lumos Pharma)?
Which analyst is the currently most bullish on LUMO (Lumos Pharma)?
Which analyst is the currently most reserved on LUMO (Lumos Pharma)?